Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes (Q44894034)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes |
scientific article |
Statements
1 reference
Pioglitazone as monotherapy or in combination with sulfonylurea or metformin enhances insulin sensitivity (HOMA-S or QUICKI) in patients with type 2 diabetes (English)
1 reference
Meng H Tan
1 reference
N Bradly Glazer
1 reference
Don Johns
1 reference
Mario Widel
1 reference
Kathryn J Gilmore
1 reference
1 reference
Identifiers
1 reference